量化COVID-19大流行的隐藏影响:细胞学视角
本研究通过时间序列分析,回顾了2019年1月至2021年4月细胞学样本,发现疫情第一波期间妇科和非妇科细胞学样本分别下降89.4%和70.4%,前3个月恶性病例减少154例,且未在后续弥补。
要点
- 疫情第一波导致细胞学样本量骤降,妇科降89.4%,非妇科降70.4%。
- 前3个月恶性诊断减少154例,后续未弥补。
- 第二波疫情影响较小,样本量降幅分别为20.1%和24.8%。
核心结论
- COVID-19大流行导致细胞学样本量显著下降,恶性诊断减少,影响超出直接死亡。
研究设计与样本
- 回顾性时间序列分析,纳入2019年1月至2021年4月的所有细胞学病理报告。
主要发现
- 第一波疫情(2020年3-6月)妇科细胞学样本下降89.4%,非妇科下降70.4%。
- 疫情前3个月恶性病例较前一年减少154例。
- 样本量缓慢恢复,但恶性诊断减少未弥补。
临床怎么用
- 需关注疫情对细胞学诊断的延迟影响,加强筛查恢复和恶性病例追踪。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The burden of the COVID-19 pandemic is often enumerated in lives lost, but the strain on health care resources and mobility limitations contributed to the burden of non-COVID related disease. In this study, we evaluated the impact of the pandemic through a time series review of cytology samples. METHODS: Pathology reports for all cytology specimens received from January 2019 through April 2021 at our institution were reviewed. Time series analysis was performed using moving averages, time trend analysis, cross-correlation, and tests of homogeneity. RESULTS: During the first peak of the pandemic (March-June 2020), breakpoint analysis showed a downward shift in the number of gynecologic (-89.4%) and non-gynecologic (-70.4%) cytology specimens within a week of declaration of an emergency. Cross-correlation analysis showed a relationship between sample numbers and COVID-19 cases during the initial phase of the pandemic (April-June 2020). During the second surge (October 2020-April 2021), despite the higher incidence of COVID-19, there was a smaller impact on cytology samples (-20.1% and - 24.8% for gynecologic and non-gynecologic samples, respectively). During the first 3 months of the pandemic, 154 fewer malignant cases were identified compared with the prior year. Although specimen numbers slowly returned to baseline following the first wave of the pandemic, the earlier decline in malignant diagnoses was not offset during the study period. CONCLUSIONS: The deleterious effects of COVID-19 extend beyond direct mortality attributed to the disease. The significant decrease in diagnostic cytology specimens during this period has profound implications including delayed care and missed disease.
引用
- Yousefi E, Cibas ES, Mito JK, et al. Quantifying the hidden impact of COVID-19 pandemic: The cytology perspective. Cancer Cytopathol. 2022. PMID: 35749134. doi:10.1002/cncy.22613
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。